Repligen Corporation
RGEN
$130.13
$4.803.83%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/9/2026
-
GuruFocus
6/7/2026
-
The Cerbat Gem
6/4/2026
-
GuruFocus
6/4/2026
-
Zacks Investment Research
6/4/2026
-
SeekingAlpha
Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript
6/3/2026
-
SeekingAlpha
6/3/2026
-
TipRanks Financial Blog
6/2/2026
-
Simply Wall St
5/31/2026
-
Seeking Alpha - Long Ideas
5/31/2026
-
SeekingAlpha
5/23/2026
-
Simply Wall St
5/23/2026
-
Tickeron - Stocks
5/22/2026
-
Globe Newswire
5/22/2026
-
Tickeron - Stocks
5/20/2026
-
Globe Newswire
5/19/2026
-
GuruFocus
5/19/2026
-
Simply Wall St
5/19/2026
-
Tickeron - Stocks
5/15/2026
-
Tickeron - Stocks
5/14/2026
-
TipRanks Financial Blog
5/14/2026
-
Tickeron - Stocks
5/14/2026
-
Tickeron - Stocks
5/13/2026
-
Tickeron - Stocks
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
5/12/2026
-
Seeking Alpha: Transcripts
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
5/12/2026
-
SeekingAlpha
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, May 6, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 250 0111
Address
Building 1
Suite 100 - 41 Seyon Street
Waltham, MA 02453
Suite 100 - 41 Seyon Street
Waltham, MA 02453
Country
Year Founded
Business Description
Sector
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company’s...
more